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Mesotheliomas are malignant tumors of the pleuraland peritoneal surfaces. They occur occasionally inthe pericardium and atrioventricular node in theheart. To our knowledge, mesotheliomas originating
from the left ventricle are rare. A case of a large malignant
mesothelioma arising from the ventricular septum in the left ven-
tricle is presented, which was treated by surgical resection.
Clinical Summary 
A 51-year-old man was admitted to the hospital because of exer-
tional dyspnea and palpitations that had increased for the past 6
months. He had no history of exposure to asbestos. On ausculta-
tion, a grade 3/6 systolic murmur was found at the apex of the
heart. Electrocardiography indicated normal sinus rhythm, and x-
ray findings of the thorax were nonspecific. Two-dimensional
transthoracic echocardiography revealed a 9.0- × 3.0-cm mobile
heterogeneous discrete mass within the left ventricle. The mass
was attached to the ventricular septum and appeared to be moving
between the left atrium and the left ventricle. Significant mitral
regurgitation was observed. Other cardiac structures were normal.
For excision of the mass, cardiopulmonary bypass was insti-
tuted with moderate hypothermia, topical cooling, and antegrade
cold cardioplegia for myocardial protection. Through a left ven-
triculotomy, a large wide pedunculated mass was found firmly
attached to the membranous part of the ventricular septum. The
tumor was solid and encapsulated, yellowish white, and mea-
sured 10 × 3 × 4 cm. It reached the orifice of the mitral valve,
but the valve was not damaged. The stalk of the tumor was
excised from the bottom, and care was taken not to damage the
region of the ventricular septum. On inspection of the pericardi-
um and left atrium, no abnormality was seen.
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Micrographic (Figure 1) and immunohistochemical examina-
tion (Figure 2) of the resected specimen confirmed a sarcomatous
mesothelioma (fibrous mesothelioma). The patient made an
uneventful postoperative recovery and maintained normal sinus
rhythm. He was discharged on the ninth postoperative day. Three
months after the operation, an echocardiogram revealed a thick-
ened ventricular septum and a normal mitral valve with no residual
mass. The patient was doing well 4 months after the operation.
Comment 
Primary cardiac tumors of the heart are rare. A total of 2.7% of
primary cardiac tumors are pericardial mesotheliomas, which usu-
ally occur independently of intracardiac lesions and infiltrate adja-
cent tissues superficially.1 Rare cases of mesotheliomas of the atri-
oventricular node have been reported.2 Primary sarcomatous
mesothelioma arising from the left ventricle is extremely uncom-
mon.
The most useful diagnostic tool is the transthoracic and trans-
esophageal 2- and 3-dimensional echocardiogram, which may
accurately identify the shape, dimensions, location, origin, surface,
and 3-dimensional movement of the tumor and involvement of
valves. The echocardiogram also allows preoperative planning for
the optimal therapeutic approach, such as valve repair or valve
replacement.3 Computed tomography and magnetic resonance
imaging are the second most important tests, because the density
of the images may allow tumor cell type to be identified.4 So that
obstruction of the valve orifice, dilation of the anulus, emboliza-
tion, and rhythm disturbances can be avoided, the tumor should be
Figure 1. Sarcomatous mesothelioma (fibrous mesothelioma) spin-
dle cells that grow in fascicles with a relatively scant amount of
fibrous stroma. (Hematoxylin and eosin stain; original magnifica-
tion ×350.)
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sectable mesothelioma, radiation and chemotherapy may be used,
but without great expectation of success.5
During the operation, it is important to prevent perioperative
embolism by thoroughly cleaning the left ventricle. Because the base
of the tumor is attached to the membranous part of the ventricular
septum, caution must be taken not to damage the conduction systems.
If the mitral valve is invaded by the tumor, it is not possible to excise
the tumor completely without sacrificing the valve, and the valve
should be replaced with a bioprosthesis. Intensive myocardial protec-
tion should be provided during the ventriculotomy.
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surgically excised, but complete resection may not be possible,
either because of the extent of local spread and invasion or because
of the frequent distant metastases. Transplantation may also be an
option for those with extensive local disease. The long-term results
for malignant mesotheliomas are very poor, with few patients sur-
viving. For the perioperative patient or the patient with unre-
Figure 2. Immunohistochemistry showing a positive reaction to
HBME-1. (LSAB ×350.)
